Alnylam Pharmaceuticals
ALNY
#628
Rank
$31.37 B
Marketcap
$243.25
Share price
0.41%
Change (1 day)
27.22%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company